Abortion Medication Access Post-Dobbs: What Healthcare Providers Need To Know

Women's Health Month Webinar Series: Post-Dobbs
 | 12 - 12:30 p.m. Central

This webinar will outline the key considerations related to the prescription, dispensing, wholesale, and manufacture of drugs which may be used for purposes of inducing an abortion at both the state and federal levels. Specifically, we will outline representative state laws with an emphasis on identifying key risk mitigation strategies for any entities or individuals involved in handling potential abortion-inducing drugs. Lastly, this webinar will provide a brief overview of the ongoing federal litigation related to the FDA approval of select mifepristone products and the concurrent interpretations of the Comstock Act.

Who Should Attend:

These sessions are designed for health systems, pharmacies, pharmacists, physicians, wholesalers, drug manufacturers and technology companies that support these healthcare entities. Quarles reserves the right to limit or restrict attendance to the program. 

Questions or Want to Register?

Please contact Sara Gaffney, sara.gaffney@quarles.com.


Related Capabilities

Follow Quarles

Subscribe Media Contact
Back to Main Content

We use cookies to provide you with the best user experience on our website and to analyze statistics related to our website. To understand more about how we use cookies, or for instructions to change your preference and browser settings, please see our Privacy Notice. Please note that if you choose to reject cookies, doing so may impair some of our website's functionality.

View My Stats